Treatment of rheumatoid arthritis with traditional Chinese medicine

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Lee, Wen Yuan ^a,b,c   Chen, Hsin Yi ^b   Chen, Kuan Chung ^d   Chen, Calvin Yu Chian ^a,b  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b ASIA UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; CALYCOSIN; CHINESE DRUG; INTERLEUKIN 6 RECEPTOR; UNCLASSIFIED DRUG; 7,3'-DIHYDROXY-4'-METHOXYISOFLAVONE; IL6R PROTEIN, HUMAN; ISOFLAVONE DERIVATIVE;

ANGELICA SINENSIS; ARTICLE; BINDING AFFINITY; CHINESE MEDICINE; DRUG SCREENING; HUMAN; HYDROGEN BOND; MOLECULAR DOCKING; MOLECULAR DYNAMICS; RHEUMATOID ARTHRITIS; ANTAGONISTS AND INHIBITORS; ARTHRITIS, RHEUMATOID; CHEMISTRY; METABOLISM; PATHOLOGY;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; HUMANS; ISOFLAVONES; MEDICINE, CHINESE TRADITIONAL; MOLECULAR DOCKING SIMULATION; MOLECULAR DYNAMICS SIMULATION; RECEPTORS, INTERLEUKIN-6;

EID: 84903584201     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/528018     Document Type: Article

References (51)

1. Scott D. L., Wolfe F., Huizinga T. W. J., Rheumatoid arthritis. The Lancet 2010 376 9746 1094 1108 2-s2.0-77957196913 10.1016/S0140-6736(10)60826-4
2. Wolfe F., Mitchell D. M., Sibley J. T., Fries J. F., Bloch D. A., Williams C. A., Spitz P. W., Haga M., Kleinheksel S. M., Cathey M. A., The mortality of rheumatoid arthritis. Arthritis and Rheumatism 1994 37 4 481 494 2-s2.0-0028328810 (Pubitemid 24115934)
3. Aviña-Zubieta J. A., Choi H. K., Sadatsafavi M., Etminan M., Esdaile J. M., Lacaille D., Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Care and Research 2008 59 12 1690 1697 2-s2.0-57149096904 10.1002/art.24092
4. Gupta A., Fomberstein B., Evaluating cardiovascular risk in rheumatoid arthritis. Journal of Musculoskeletal Medicine 2009 26 8 481 494
5. Mahamuni S. P., Khose R. D., Menaa F., Badole S. L., Therapeutic approaches to drug targets in hyperlipidemia. BioMedicine 2012 2 4 137 146 2-s2.0-84871609281 10.1016/j.biomed.2012.08.002
6. Chou I.-C., Lin W.-D., Wang C.-H., Chang Y.-T., Chin Z.-N., Tsai C.-H., Tsai F.-J., Association analysis between Tourette's syndrome and two dopamine genes (DAT1, DBH) in Taiwanese children. BioMedicine 2013 3 2 88 91 2-s2.0-84876081328 10.1016/j.biomed.2013.02.003
7. Yamamoto T., Hung W.-C., Takano T., Nishiyama A., Genetic nature and virulence of community-associated methicillin-resistant Staphylococcus aureus. BioMedicine 2013 3 1 2 18 2-s2.0-84875259470 10.1016/j.biomed.2012.12.001
8. Chang Y.-M., Velmurugan B. K., Kuo W.-W., Chen Y.-S., Ho T.-J., Tsai C.-T., Ye C.-X., Tsai C.-H., Tsai F.-J., Huang C.-Y., Inhibitory effect of alpinate Oxyphyllae fructus extracts on Ang II-induced cardiac pathological remodeling-related pathways in H9c2 cardiomyoblast cells. BioMedicine 2013 3 148 152 2-s2.0-84878732300 10.1016/j.biomed.2013.05.001
9. 2+ store-depleted rat insulinoma RINm5F cells. BioMedicine 2013 3 3 130 139 2-s2.0-84881370670 10.1016/j.biomed.2012.11.003
10. Jiang Y., Li X., Yang W., PKM2 regulates chromosome segregation and mitosis progression of tumor cells. Molecular Cell 2014 53 1 75 87
11. Janssens V., Goris J., Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling. Biochemical Journal 2001 353 3 417 439 2-s2.0-0035252894 10.1042/0264-6021: 3530417 (Pubitemid 32158309)
12. Su K.-P., Inflammation in psychopathology of depression: clinical, biological, and therapeutic implications. BioMedicine 2012 2 2 68 74 2-s2.0-84862764317 10.1016/j.biomed.2012.03.002
13. Leissring M. A., Malito E., Hedouin S., Reinstatler L., Sahara T., Abdul-Hay S. O., Choudhry S., Maharvi G. M., Fauq A. H., Huzarska M., May P. S., Choi S., Logan T. P., Turk B. E., Cantley L. C., Manolopoulou M., Tang W.-J., Stein R. L., Cuny G. D., Selkoe D. J., Designed inhibitors of insulin-degrading enzyme regulate the catabolism and activity of insulin. PLoS ONE 2010 5 5 2-s2.0-77956274306 10.1371/journal.pone.0010504 e10504
14. Jao C.-L., Huang S.-L., Hsu K.-C., Angiotensin I-converting enzyme inhibitory peptides: inhibition mode, bioavailability, and antihypertensive effects. BioMedicine 2012 2 4 130 136 2-s2.0-84871621268 10.1016/j.biomed.2012. 06.005
15. Lin M.-C., Tsai S.-Y., Wang F.-Y., Liu F.-H., Syu J.-N., Tang F.-Y., Leptin induces cell invasion and the upregulation of matrilysin in human colon cancer cells. BioMedicine 2013 3 4 174 180
16. Okada Y., Wu D., Trynka G., Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature 2013 506 376 381 10.1038/nature12873
17. Moots R. J., Östör A. J. K., Isaacs J. D., Will treatment of rheumatoid arthritis with an IL-6R inhibitor help facilitate the "age of remission"? Expert Opinion on Investigational Drugs 2009 18 11 1687 1699 2-s2.0-73849131345 10.1517/14728220903185939
18. Edwards J. C. W., Cambridge G., Abrahams V. M., Do self-perpetuating B lymphocytes drive human autoimmune disease? Immunology 1999 97 2 188 196 2-s2.0-0033033201 10.1046/j.1365-2567.1999.00772.x (Pubitemid 29274149)
19. Plenge R. M., Seielstad M., Padyukov L., Lee A. T., Remmers E. F., Ding B., Liew A., Khalili H., Chandrasekaran A., Davies L. R. L., Li W., Tan A. K. S., Bonnard C., Ong R. T. H., Thalamuthu A., Pettersson S., Liu C., Tian C., Chen W. V., Carulli J. P., Beckman E. M., Altshuler D., Alfredsson L., Criswell L. A., Amos C. I., Seldin M. F., Kastner D. L., Klareskog L., Gregersen P. K., TRAF1-C5 as a risk locus for rheumatoid arthritis-a genomewide study. The New England Journal of Medicine 2007 357 12 1199 1209 2-s2.0-34548849168 10.1056/NEJMoa073491 (Pubitemid 47443179)
20. Goeldner I., Skare T. L., de Messias Reason I. T., Nisihara R. M., Silva M. B., da Rosa Utiyama S. R., Anti-cyclic citrullinated peptide antibodies and rheumatoid factor in rheumatoid arthritis patients and relatives from Brazil. Rheumatology 2010 49 8 1590 1593 2-s2.0-77954701093 10.1093/rheumatology/keq134
21. Silman A. J., MacGregor A. J., Thomson W., Holligan S., Carthy D., Farhan A., Ollier W. E. R., Twin concordance rates for rheumatoid arthritis: results from a nationwide study. British Journal of Rheumatology 1993 32 10 903 907 2-s2.0-0027375302 (Pubitemid 23301303)
22. Bellamy N., Duffy D., Martin N., Mathews J., Rheumatoid arthritis in twins: a study of aetiopathogenesis based on the Australian Twin Registry. Annals of the Rheumatic Diseases 1992 51 5 588 593 2-s2.0-0026550305
23. Sugiyama D., Nishimura K., Tamaki K., Tsuji G., Nakazawa T., Morinobu A., Kumagai S., Impact of smoking as a risk factor for developing rheumatoid arthritis: a meta-analysis of observational studies. Annals of the Rheumatic Diseases 2010 69 1 70 81 2-s2.0-73449098950 10.1136/ard.2008.096487
24. Liao K. P., Alfredsson L., Karlson E. W., Environmental influences on risk for rheumatoid arthritis. Current Opinion in Rheumatology 2009 21 3 279 283 2-s2.0-67650170347 10.1097/BOR.0b013e32832a2e16
25. Wen H., Baker J. F., Vitamin D, immunoregulation, and rheumatoid arthritis. Journal of Clinical Rheumatology 2011 17 2 102 107 2-s2.0-79952405704 10.1097/RHU.0b013e31820edd18
26. Rheumatoid Arthritis Patients Have Double the Risk of Heart Failure. Science News, 2005, http://www.mayoclinic.org/
27. Cardiac Disease in Rheumatoid Arthritis 2002 John Hopkins University
28. Lin D.-Y., Tsai F.-J., Tsai C.-H., Huang C.-Y., Mechanisms governing the protective effect of 17 β -estradiol and estrogen receptors against cardiomyocyte injury. BioMedicine 2011 1 1 21 28 2-s2.0-84861187789 10.1016/j.biomed.2011.10.004
29. Liao W.-L., Tsai F.-J., Personalized medicine: a paradigm shift in healthcare. BioMedicine 2013 3 2 66 72 2-s2.0-84873509576 10.1016/j.biomed.2012. 12.005
30. Lee C.-C., Tsai C.-H., Wan L., Increased incidence of Parkinsonism among Chinese with β -glucosidase mutation in central Taiwan. BioMedicine 2013 3 2 92 94
31. Chou I.-C., Lin W.-D., Wang C.-H., Möbius syndrome in a male with XX/XY mosaicism. BioMedicine 2013 3 2 102 104
32. Chang Y.-T., Lin W.-D., Chin Z.-N., Wang C.-S., Chou I.-C., Kuo H.-T., Tsai F.-J., Nonketotic hyperglycinemia: a case report and brief review. BioMedicine 2012 2 2 80 82 2-s2.0-84862762574 10.1016/j.biomed.2012.04.002
33. Chen C.-Y., Chen C. Y.-C., Insights into designing the dual-targeted HER2/HSP90 inhibitors. Journal of Molecular Graphics and Modelling 2010 29 1 21 31 2-s2.0-77955772552 10.1016/j.jmgm.2010.04.002
34. Yang S.-C., Chang S.-S., Chen H.-Y., Chen C. Y.-C., Identification of potent EGFR inhibitors from TCM Database@Taiwan. PLoS Computational Biology 2011 7 10 2-s2.0-80055077153 10.1371/journal.pcbi.1002189 e1002189
35. Tsou Y.-A., Chen K.-C., Lin H.-C., Chang S.-S., Chen C. Y.-C., Uroporphyrinogen decarboxylase as a potential target for specific components of traditional Chinese medicine: a virtual screening and molecular dynamics study. PLoS ONE 2012 7 11 2-s2.0-84870550823 10.1371/journal.pone.0050087 e50087
36. Chen K.-C., Sun M.-F., Yang S.-C., Chang S.-S., Chen H.-Y., Tsai F.-J., Chen C. Y.-C., Investigation into potent inflammation inhibitors from traditional Chinese medicine. Chemical Biology and Drug Design 2011 78 4 679 688 2-s2.0-80052619174 10.1111/j.1747-0285.2011.01202.x
37. Chen K.-C., Yu-Chian Chen C., Stroke prevention by traditional Chinese medicine? A genetic algorithm, support vector machine and molecular dynamics approach. Soft Matter 2011 7 8 4001 4008 2-s2.0-79953746295 10.1039/c0sm01548b
38. Chen K.-C., Chang K.-W., Chen H.-Y., Chen C. Y.-C., Traditional Chinese medicine, a solution for reducing dual stroke risk factors at once? Molecular BioSystems 2011 7 9 2711 2719 2-s2.0-80051760684 10.1039/c1mb05164d
39. Chang T.-T., Chen K.-C., Chang K.-W., Chen H.-Y., Tsai F.-J., Sun M.-F., Chen C. Y.-C., In silico pharmacology suggests ginger extracts may reduce stroke risks. Molecular BioSystems 2011 7 9 2702 2710 2-s2.0-80051767195 10.1039/c1mb05228d
40. Tou W. I., Chang S.-S., Lee C.-C., Chen C. Y.-C., Drug design for neuropathic pain regulation from traditional Chinese medicine. Scientific Reports 2013 3, article 844 2-s2.0-84880533871
41. Chen C. Y.-C., A novel integrated framework and improved methodology of computer-aided drug design. Current Topics in Medicinal Chemistry 2013 13 9 965 988 2-s2.0-84878775187 10.2174/1568026611313090002
42. Chen C. Y.-C., TCM Database@Taiwan: the world's largest traditional Chinese medicine database for drug screening In Silico. PLoS ONE 2011 6 1 2-s2.0-79251561193 10.1371/journal.pone.0015939 e15939
43. Varghese J. N., Moritz R. L., Lou M.-Z., Van Donkelaar A., Ji H., Ivancic N., Branson K. M., Hall N. E., Simpson R. J., Structure of the extracellular domains of the human interleukin-6 receptor α -chain. Proceedings of the National Academy of Sciences of the United States of America 2002 99 25 15959 15964 2-s2.0-18744394296 10.1073/pnas.232432399 (Pubitemid 35462731)
44. Xue B., Dunbrack R. L., Williams R. W., Dunker A. K., Uversky V. N., PONDR-FIT: a meta-predictor of intrinsically disordered amino acids. Biochimica et Biophysica Acta-Proteins and Proteomics 2010 1804 4 996 1010 2-s2.0-76849087968 10.1016/j.bbapap.2010.01.011
45. Ganesan A., The impact of natural products upon modern drug discovery. Current Opinion in Chemical Biology 2008 12 3 306 317 2-s2.0-44949134801 10.1016/j.cbpa.2008.03.016
46. Keller T. H., Pichota A., Yin Z., A practical view of 'druggability'. Current Opinion in Chemical Biology 2006 10 4 357 361 2-s2.0-33746071900 10.1016/j.cbpa.2006.06.014 (Pubitemid 44080649)
47. Khan M. T. H., Predictions of the ADMET properties of candidate drug molecules utilizing different QSAR/QSPR modelling approaches. Current Drug Metabolism 2010 11 4 285 295 2-s2.0-77953314142 10.2174/138920010791514306
48. Brooks B. R., Brooks C. L. III, Mackerell A. D. Jr., Nilsson L., Petrella R. J., Roux B., Won Y., Archontis G., Bartels C., Boresch S., Caflisch A., Caves L., Cui Q., Dinner A. R., Feig M., Fischer S., Gao J., Hodoscek M., Im W., Kuczera K., Lazaridis T., Ma J., Ovchinnikov V., Paci E., Pastor R. W., Post C. B., Pu J. Z., Schaefer M., Tidor B., Venable R. M., Woodcock H. L., Wu X., Yang W., York D. M., Karplus M., CHARMM: the biomolecular simulation program. Journal of Computational Chemistry 2009 30 10 1545 1614 2-s2.0-67650500988 10.1002/jcc.21287
49. Hess B., Kutzner C., van der Spoel D., Lindahl E., GRGMACS 4: algorithms for highly efficient, load-balanced, and scalable molecular simulation. Journal of Chemical Theory and Computation 2008 4 3 435 447 2-s2.0-46249092554 10.1021/ct700301q
50. Maiorov V. N., Crippen G. M., Size-independent comparison of protein three-dimensional structures. Proteins: Structure, Function and Genetics 1995 22 3 273 283 2-s2.0-0029057126 10.1002/prot.340220308
51. Chovancova E., Pavelka A., Benes P., Strnad O., Brezovsky J., Kozlikova B., Gora A., Sustr V., Klvana M., Medek P., Biedermannova L., Sochor J., Damborsky J., CAVER 3.0: a tool for the analysis of transport pathways in dynamic protein structures. PLoS Computational Biology 2012 8 10 2-s2.0-84868156224 10.1371/journal.pcbi.1002708 e1002708